These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2492089)

  • 1. Claims on tissue plasminogen activator.
    Crespi RS
    Nature; 1989 Jan; 337(6205):317-8. PubMed ID: 2492089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems over TPA patent for Genentech in Japan.
    Swinbanks D
    Nature; 1988 Jun; 333(6174):587. PubMed ID: 3131683
    [No Abstract]   [Full Text] [Related]  

  • 3. New battle over TPA.
    Ezzell C
    Nature; 1989 Aug; 340(6233):418. PubMed ID: 2502715
    [No Abstract]   [Full Text] [Related]  

  • 4. Genentech patent.
    Nature; 1988 Sep; 335(6186):105. PubMed ID: 3137476
    [No Abstract]   [Full Text] [Related]  

  • 5. TPA patent battle rages in United Kingdom.
    Johnston K
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108671
    [No Abstract]   [Full Text] [Related]  

  • 6. Boehringer Mannheim's new clot buster.
    Nat Biotechnol; 1997 Feb; 15(2):114. PubMed ID: 9035121
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality control of rDNA-derived human tissue-type plasminogen activator.
    Jones AJ; Garnick RL
    Bioprocess Technol; 1990; 10():543-66. PubMed ID: 1367501
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotechnology. All systems go in Britain.
    Newmark P
    Nature; 1986 Mar 13-19; 320(6058):100. PubMed ID: 2419766
    [No Abstract]   [Full Text] [Related]  

  • 9. Genentech gets patent protection for tissue plasminogen activator.
    Ezzell C
    Nature; 1988 Jun; 333(6176):790. PubMed ID: 3133565
    [No Abstract]   [Full Text] [Related]  

  • 10. TPA patent battle continues in court.
    Johnston K
    Nature; 1987 Jun 18-24; 327(6123):546. PubMed ID: 3110620
    [No Abstract]   [Full Text] [Related]  

  • 11. Defining the scope of biotech patent claims.
    McGough KJ
    Biotechnology (N Y); 1995 Apr; 13(4):318-9. PubMed ID: 9678945
    [No Abstract]   [Full Text] [Related]  

  • 12. First US patent on TPA for Oxford University.
    Ezzell C
    Nature; 1988 Jun; 333(6172):383. PubMed ID: 3131680
    [No Abstract]   [Full Text] [Related]  

  • 13. US patents in the balance.
    Ezzell C
    Nature; 1987 Jul 16-22; 328(6127):189. PubMed ID: 3110625
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory and clinical experience with recombinant plasminogen activator.
    Builder SE; Grossbard E
    Prog Clin Biol Res; 1986; 211():303-13. PubMed ID: 3083430
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].
    Páramo JA; Fernández FJ; Cuesta B; Paloma MJ; Rocha E
    Sangre (Barc); 1989 Aug; 34(4):297-9. PubMed ID: 2505395
    [No Abstract]   [Full Text] [Related]  

  • 16. Alteplase (rtPA) patent case.
    Brahams D
    Lancet; 1988 Nov; 2(8622):1263. PubMed ID: 2904002
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recombinant murine cell lines, transformed by various vectors based on bovine type 1 papillomavirus and expressing human tissue plasminogen activator. II. Analysis of cell lines, producing recombinant tissue plasminogen activator].
    Aleshkov SB; Ustav MB; Baev AA
    Mol Biol (Mosk); 1994; 28(3):619-25. PubMed ID: 8052253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serpin-resistant mutants of human tissue-type plasminogen activator.
    Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF
    Nature; 1989 Jun; 339(6227):721-4. PubMed ID: 2500599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPO patient dispute: court battle ends at the start.
    Gershon D
    Nature; 1989 Dec 21-28; 342(6252):846. PubMed ID: 2594071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.